Publications Office of the EU
Poland-Białystok: Pharmaceutical products - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Poland-Białystok: Pharmaceutical products

  • Published
    10/08/2022
  • Deadline
    07/09/2022
  • Awarded
    25/10/2022
  • Today
    11/08/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Białostockie Centrum Onkologii im. M. Skłodowskiej-Curie w Białymstoku
Place of performance
NUTS code: PL841 Białostocki
Location of buyer
NUTS code: PL841 Białostocki
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
9,189,873.85 PLN
Please consult each lot for details
Number of lots
108
Tender reference number
DZP.261.16.2022
Description

Przedmiotem zamówienia jest dostawa produktów leczniczych, wyrobów medycznych i innych produktów, w ilościach, asortymencie oraz o wymaganiach jakościowych odnoszących się do co najmniej głównych elementów składających się na przedmiot zamówienia. Przedmiot zamówienia został szczegółowo opisany w Załącznikach nr 2A i 2B do SWZ.

Submission Method
Electronic via:
https://miniportal.uzp.gov.pl/
Tenders may be submitted
Submission for all lots
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Check linked documents for details
Place of performance
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.